Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-04-13

Clinical Trial Update: A Study to Look at the Effect MEDI0382 Has on Blood Sugar in People With Type 2 Diabetes and Kidney Problems and Also to Check That MEDI0382 is Well Tolerated [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating MEDI0382's effect on blood sugar in type 2 diabetes with renal impairment and assessing tolerability.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MEDI0382

Snippet

Sponsor: MedImmune LLC | Conditions: Type II Diabetes Mellitus, Renal Insufficiency | Phase 2 | Status: COMPLETED | Results posted: 2020-04-13